Previous 10 | Next 10 |
BRISBANE, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that the company will be presenting data from its Phase 2 MAVERICK-HCM clinical trial during a late-breaker session at the upcoming American College of Cardiology’s 69 th Annual Scien...
Today, we will see why Cytokinetics ( CYTK ) can be an attractive pick in 2020. Company overview Cytokinetics is a clinical-stage biotechnology company focused on developing innovative treatment options targeting cardiovascular and neuromuscular diseases caused due to impaired muscle fun...
Image source: The Motley Fool. MyoKardia, Inc. (NASDAQ: MYOK) Q4 2019 Earnings Call Feb 27, 2020 , 4:30 p.m. ET Operator Continue reading
Foreword This article is based on a Kiplinger Investing article aimed to find analysts' top stock picks for 2020 , the author, Maya Sasson, published 12/23/19, used "analyst-tracking data to discover the best of the bunch – stocks that have loads of upside potential from current sh...
MyoKardia, Inc. (MYOK) Q4 2019 Earnings Conference Call February 27, 2020 4:30 P.M. ET Company Participants Michelle Corral - Executive Director of Corporate Communications and Investor Relations Tassos Gianakakos - Chief Executive Officer Jay Edelberg - Senior Vice President, Cl...
MyoKardia (NASDAQ: MYOK ): Q4 GAAP EPS of -$1.27 beats by $0.19 . More news on: MyoKardia, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
BRISBANE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the fourth quarter and full year ended December 31, 2019. “MyoKardia achieved significant progress in 2019, advancing our pipeline and regaining global rights t...
BRISBANE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will present at the 40 th Annual Cowen Health Care Conference on Monday, March 2 nd 2020 at 1:30 p.m. EST in Boston. A webcast of the pr...
BRISBANE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report fourth quarter and full year 2019 financial and operating results on Thursday, February 27, 2020. Management will host a conference call and live audio webcast to discuss ...
The following slide deck was published by MyoKardia, Inc. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
EXPLORER -HCM Cardiac Imaging Data Presented at AHA 2020 Scientific Session with Simultaneous Publication in Circulation Mavacamten T reatment Resulted in Favorable Effect on Cardiac Structure -- Significantly Reduced Hypertrophy in Patien...
ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients Markers of Physical Activity from MAVERICK-HCM Accelerometry Data Correlated with ...
BRISBANE, Calif. and WASHINGTON, Nov. 11, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (NASDAQ: MYOK), and the American College of Cardiology (ACC) announced the establishment of a nationwide registry of hypertrophic cardiomyopathy (HCM), which leverages the ACC’s PINNACLE Cardiovas...